SGK3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.303200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.787600E-01
Normal-vs-Stage2
1.616390E-01
Normal-vs-Stage3
6.464800E-03
Normal-vs-Stage4
1.624980E-01
Stage1-vs-Stage2
4.738800E-01
Stage1-vs-Stage3
4.433700E-02
Stage1-vs-Stage4
5.818200E-01
Stage2-vs-Stage3
2.199300E-03
Stage2-vs-Stage4
9.747800E-01
Stage3-vs-Stage4
6.769900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.504000E-01
Normal-vs-AfricanAmerican
5.703800E-01
Normal-vs-Asian
1.011640E-01
Caucasian-vs-AfricanAmerican
7.574000E-01
Caucasian-vs-Asian
1.331630E-01
AfricanAmerican-vs-Asian
1.676840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.328000E-01
Normal-vs-Female
2.458000E-01
Male-vs-Female
5.651800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.876210E-01
Normal-vs-Age(41-60Yrs)
4.273600E-01
Normal-vs-Age(61-80Yrs)
8.128000E-01
Normal-vs-Age(81-100Yrs)
1.344040E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.773200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.832000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.548800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.347600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.589000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.266200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.826100E-02
Normal-vs-Daily Drinker
8.304300E-02
Normal-vs-Weekly Drinker
1.268810E-01
Normal-vs-Occasional Drinker
5.387600E-01
Normal-vs-Social Drinker
5.093800E-01
Non Drinker-vs-Daily Drinker
8.934600E-01
Non Drinker-vs-Weekly Drinker
8.130400E-01
Non Drinker-vs-Occasional Drinker
3.429000E-01
Non Drinker-vs-Social Drinker
1.876000E-01
Daily Drinker-vs-Weekly Drinker
9.197800E-01
Daily Drinker-vs-Occasional Drinker
4.031800E-01
Daily Drinker-vs-Social Drinker
2.078800E-01
Weekly Drinker-vs-Occasional Drinker
5.030600E-01
Weekly Drinker-vs-Social Drinker
3.214400E-01
Occasional Drinker-vs-Social Drinker
8.616000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.683800E-01
Normal-vs-Grade 2
4.026500E-02
Normal-vs-Grade 3
8.132400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.499600E-01
Grade 1-vs-Grade 3
2.516000E-01
Grade 1-vs-Grade 4
5.683800E-01
Grade 2-vs-Grade 3
9.904400E-01
Grade 2-vs-Grade 4
4.026500E-02
Grade 3-vs-Grade 4
8.132400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.392200E-01
Normal-vs-NonDiabetic
7.715800E-01
Diabetic-vs-NonDiabetic
7.293200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.052250E-02
Normal-vs-NoPancreatitis
7.825200E-01
Pancreatitis-vs-NoPancreatitis
4.174500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.551600E-01
Normal-vs-N1
1.856440E-01
N0-vs-N1
4.148400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.812000E-02
Normal-vs-TP53-NonMutant
8.704000E-01
TP53-Mutant-vs-TP53-NonMutant
7.788000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
